LR Health & Beauty SE Confirms Growth Trend in Q2 2024

LR Health & Beauty SE, Europe’s leading digital social commerce company, has confirmed a positive growth trend in the second quarter of 2024. Sales revenue increased to EUR 70.7 million, up by 2.6% from EUR 68.9 million in Q2 2023. For the first half of 2024, sales reached EUR 143.3 million, compared to EUR 140.9 million in H1 2023.

The company's normalized EBITDA for the first six months was EUR 14.4 million, down from EUR 17.5 million from the previous year. This decline was due to refinancing costs and negative currency effects. Reported EBITDA stood at EUR 11.7 million, compared to EUR 15.4 million in the same period last year.

Valdemaras Gordinskis highlighted the growing demand for the subscription service LR Health Mission. CEO Dr Andreas Laabs emphasized the focus on optimizing marketing activities and expanding the product range, with a new segment launch planned for September.

Future growth for LR Health & Beauty SE is expected to be driven by digitization initiatives, including the establishment of a new IT hub in Athens. The company remains cautious, expecting stable sales and EBITDA for the rest of the year.